Betaxolol
It is a selective (b1-adrenergic) receptor blocking agent when instilled in the eye reduces elevated as well as normal intraocular pressure, whether or not accompained by glaucoma. It does not have significant membrane stabilising (local anaesthetic) activity and is devoid of intrinsic sympathomimetic action.Ocular hypertension and chronic open angle glaucoma.
1drop instilled in the affected eye(s)twice daily.
Sinus bradycardia greater than a first degree atrioventricular block, cardiogenic shock or a histroy of overt cardiac failure and in patients with hypersensitivity.
Not for injection. Diabetes, thyrotoxicosis. History of obstructive pulmonary disease, cardiac failure. Potential additive effect if given with oral b-adrenergic blocking agent. It should be used with a miotic to reduce elevated intra ocular pressure in angle - closure glaucoma. Pregnant & lactating women, children.
Decreased corneal sensitivity, erythema, itching, corneal punctate staining keratitis, anisocoria & photophobia.
Enhances calcium channel blockers, anaesthetics and clonidine.
Brand Name | Manufactured by |
---|---|
BETAPRESS | MICROVISION |
Brand Name | Manufactured by |
---|---|
IOBET | FDC LTD. |
OCUPRES-B | CADILA PHARMACEUTICALS LTD. |